This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Università Degli Studi Di Roma "La Sapienza", Fondazione Istituto Italiano Di Tecnologia, Universitá Degli Studi Di Siena. Active years: 2018-2021.
Location History:
- Rome, IT (2018)
- Latina, IT (2021)
Company Filing History:
2 out of 63 
1 out of 146 
1 out of 18 Years Active: 2018-2021
Title: Cinzia Ingallina: Innovator in Cancer Treatment
Introduction
Cinzia Ingallina is a prominent inventor based in Latina, Italy. She has made significant contributions to the field of cancer treatment, particularly in the development of innovative compounds targeting specific pathways involved in tumor growth. With a total of 2 patents, her work is paving the way for new therapeutic options in oncology.
Latest Patents
Cinzia's latest patents include groundbreaking inventions such as "Notch inhibitors for use in the treatment of T-cell acute lymphoblastic leukemia." This patent focuses on compounds that exhibit anti-tumor activity specifically for T-cell acute lymphoblastic leukemia (T-ALL). Another notable patent is "Multitarget hedgehog pathway inhibitors and uses thereof," which concerns compounds that selectively inhibit the Hedgehog (Hh) pathway. These compounds are particularly useful in treating Hh-dependent tumors, such as medulloblastoma (MB).
Career Highlights
Throughout her career, Cinzia has worked with esteemed institutions, including the Università Degli Studi Di Roma "La Sapienza" and the Fondazione Istituto Italiano Di Tecnologia. Her research has significantly advanced the understanding and treatment of various cancers, showcasing her dedication to improving patient outcomes.
Collaborations
Cinzia has collaborated with notable colleagues, including Bruno Botta and Mattia Mori. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to impactful discoveries in cancer research.
Conclusion
Cinzia Ingallina's contributions to cancer treatment through her innovative patents highlight her role as a leading inventor in the field. Her work continues to inspire advancements in therapeutic strategies for challenging diseases.